Octomera的封面图片
Octomera

Octomera

制药业

Evolving cell and gene therapy (CGT) production with a decentralized approach.

关于我们

Octomera is enabling decentralized point of care cell and gene therapy (CGT)?production with support services and flexible capacity via agnostic OMPULS (Octomera Mobile Processing Units & Labs).

所属行业
制药业
规模
51-200 人
类型
私人持股
创立
2022
领域
Cell and gene therapy、Process development、Quality management、Regulatory compliance、GMP commercialization和Scalable production

Octomera员工

动态

相似主页

查看职位